Have you ever placed a prostate cancer patient on intermittent rather than continuous androgen deprivation therapy?

Share this article:

Recent studies have looked at the use of intermittent androgen deprivation therapy (ADT) as a way to spare prostate cancer (PCa) patients some of the adverse effects associated with continuous ADT.

Study findings presented at the American Urological Association 2012 annual meeting found that intermittent ADT was associated with improved overall and PCa-specific survival in elderly men with advanced disease. But data presented at the American Society of Clinical Oncology 2012 annual meeting showed that while intermittent ADT has some quality-of-life benefits for men with metastatic PCa, overall survival times are inferior to those seen with continuous ADT.

Renal & Urology News would like to get an idea of the extent to which urologists are using intermittent ADT, so please take a few moments to answer the following question:


Leave a comment below to explain your choice.
Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

Are you surprised that targeted therapeutics for metastatic renal cell carcinoma (RCC) have not improved survival?

Are you surprised that targeted therapeutics for metastatic ...

A study found that targeted therapeutic agents for treating metastatic RCC has not led to an improvement in survival rates.

Do drug stores have an ethical obligation to stop selling tobacco products?

Do drug stores have an ethical obligation to ...

CVS announced that it would no longer sell cigarettes or other tobacco products at its stores.

When was the last time you performed a venipuncture for a routine blood test?

When was the last time you performed a ...

Millions of blood tests are performed annually, many to monitor PSA levels following prostate cancer treatment or to check uric levels.